Company / Operating Income
Neurogene Inc. Operating Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$82.6M
FY2025
5-year range
-$82.6M / -$37.6M
FY2021-FY2025
Trend
-48.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has declined for 3 consecutive years, from -$38M in FY2018 to -$83M in FY2025.
Based on SEC 10-K filings.
-$83M in FY2025.
Declined from -$51M to -$83M over the past 6 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Neurogene Inc.'s operating income has declined for 3 consecutive years.
- In FY2025, operating income decreased 48.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.24 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$82.6M | -48.6% |
| FY2024 | -$55.6M | -8.7% |
| FY2019 | -$51.1M | -35.8% |
| FY2018 | -$37.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026